Rapid Readouts: Results from the Phase 3 ANDROMEDA Study - Episode 1

Results From the Phase 3 ANDROMEDA Trial for Daratumumab in Newly Diagnosed Amyloidosis

January 14, 2021

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Now Playing: Results From the Phase 3 ANDROMEDA Trial for Daratumumab in Newly Diagnosed Amyloidosis

    x